Literature DB >> 12121275

FcgammaRIIA, FcgammaRIIIA and FcgammaRIIIB polymorphisms in Spanish patients with systemic lupus erythematosus.

M F González-Escribano1, F Aguilar, J Sánchez-Román, A Núñez-Roldán.   

Abstract

Linkage studies on human families suggest that receptors for the Fc fragments of immunoglobulin G (IgG) (FcgammaRs) could be implicated in the susceptibility to, or the progression of, some autoimmune diseases. In this work we analyse the possible role of polymorphic variants of FcgammaRIIA, FcgammaRIIIA and FcgammaRIIIB genes in the susceptibility to systemic lupus erythematosus, the prototype systemic autoimmune disease. A total of 276 Spanish patients (34 male and 242 female) with systemic lupus erythematosus were included in this cross-sectional study. The FcgammaRIIA-131, FcgammaRIIIA-176 and FcgammaRIIIB-NA1/NA2 polymorphisms were investigated in the patient group as well as in 194 ethnically matched controls using polymerase chain reaction-amplification refractory mutation system (PCR-ARMS). Statistical comparisons of genotype frequencies were performed using the chi2 test. In the case of the FcgammaRIIIB-NA1/NA2 polymorphism, an increase in the frequency of homozygous NA2/NA2 in patients was found (61.2 vs. 51.0%; P = 0.03; OR = 1.5; 95% CI = 1.03-2.24), as well as a decrease in the frequency of the NA1/NA2 genotype (28 vs. 38.7%; P = 0.02; OR = 0.6; 95% CI = 0.41-0.92). These associations were independent of patient gender and HLA-DRB1 specificities. With respect to the FcgammaRIIA-131 and FcgammaRIIIA-176 polymorphisms, no differences were found between patients and controls. Patient stratification according to their lupus-related nephritis status gave similar genotypic distribution patterns in both disease categories in all the cases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121275     DOI: 10.1046/j.1365-2370.2002.00324.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  10 in total

Review 1.  Activating and inhibitory FcgammaRs in autoimmune disorders.

Authors:  Falk Nimmerjahn
Journal:  Springer Semin Immunopathol       Date:  2006-10-01

Review 2.  Functional and clinical consequences of Fc receptor polymorphic and copy number variants.

Authors:  S Bournazos; J M Woof; S P Hart; I Dransfield
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

3.  Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus.

Authors:  David L Morris; Amy L Roberts; Abigail S Witherden; Ruth Tarzi; Paula Barros; John C Whittaker; Terence H Cook; Timothy J Aitman; Timothy J Vyse
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

4.  Lack of association of FcγRIIIb polymorphisms with systemic lupus erythematosus: a meta-analysis.

Authors:  Hui Yuan; Jin-Dong Ni; Hai-Feng Pan; Lian-Hong Li; Jin-Bao Feng; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2010-03-19       Impact factor: 2.631

5.  Meta analysis on the association between FcgammaRIIa-R/H131 polymorphisms and systemic lupus erythematosus.

Authors:  Hui Yuan; Hai-Feng Pan; Lian-Hong Li; Jin-Bao Feng; Wen-Xian Li; Xiang-Pei Li; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2008-06-06       Impact factor: 2.316

Review 6.  Nonendocrine mechanisms of sex bias in rheumatic diseases.

Authors:  Nathalie C Lambert
Journal:  Nat Rev Rheumatol       Date:  2019-10-09       Impact factor: 20.543

7.  Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE.

Authors:  Meggan Mackay; Anfisa Stanevsky; Tao Wang; Cynthia Aranow; Margaret Li; Scott Koenig; Jeffrey V Ravetch; Betty Diamond
Journal:  J Exp Med       Date:  2006-08-21       Impact factor: 14.307

Review 8.  Human FcR polymorphism and disease.

Authors:  Xinrui Li; Andrew W Gibson; Robert P Kimberly
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 9.  Comprehensive Assessment of the Association between FCGRs polymorphisms and the risk of systemic lupus erythematosus: Evidence from a Meta-Analysis.

Authors:  Xiao-Wei Zhu; Yong Wang; Yi-Hua Wei; Pian-Pian Zhao; Xiao-Bo Wang; Jing-Jing Rong; Wen-Ying Zhong; Xing-Wei Zhang; Li Wang; Hou-Feng Zheng
Journal:  Sci Rep       Date:  2016-08-19       Impact factor: 4.379

10.  Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index.

Authors:  Mansoor Karimifar; Khosro Akbari; Reza ArefNezhad; Farshid Fathi; Mohammad Mousaei Ghasroldasht; Hossein Motedayyen
Journal:  BMC Res Notes       Date:  2021-12-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.